Literature DB >> 27055386

Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient.

P Ingiliz1, C Mayr2, M Obermeier3, H Herbst4, S Polywka5, S Pischke6.   

Abstract

Chronic hepatitis E has been described several times in strongly immunosuppressed HIV-patients. We describe the persistence of HEV-infection in an HIV-patient despite a restored immune response. This case demonstrates that HEV-infection can persist in formerly immunosuppressed individuals irrespective of the current immune status. Persisting HEV-infection can lead to chronic inflammation and liver cirrhosis. Physicians should be aware of the possibility of chronic hepatitis E even in patients that are not any longer immunocompromised. However, ribavirin is an efficient treatment option.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27055386     DOI: 10.1016/j.clinre.2016.01.005

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  13 in total

Review 1.  Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.

Authors:  Nassim Kamar; Sven Pischke
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

Review 2.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

3.  Shear wave elastography-based liver fibrosis assessment in patients with chronic hepatitis E displays elevated liver stiffness regardless of previous antiviral therapy.

Authors:  Marten Schulz; Mira Choi; Friederike Bachmann; Nadine Koch; Theresa Maria Holtmann; Raphael Mohr; Frank Tacke; Alexander Wree
Journal:  Quant Imaging Med Surg       Date:  2022-07

4.  Chronic hepatitis E virus infection in a cirrhotic patient: A case report.

Authors:  Hugo Barragué; Bertrand Condat; Nicolas Petitdidier; Eric Champagne; Christophe Renou; Jacques Izopet; Florence Abravanel
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

5.  High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland.

Authors:  Anna Parfieniuk-Kowerda; Jerzy Jaroszewicz; Tadeusz W Łapiński; Mariusz Łucejko; Magdalena Maciaszek; Magdalena Świderska; Anna Grzeszczuk; Beata Naumnik; Mirosław Rowiński; Robert Flisiak
Journal:  Arch Med Sci       Date:  2018-12-05       Impact factor: 3.318

Review 6.  Acute Hepatitis E: Two Sides of the Same Coin.

Authors:  Johannes Hartl; Malte H Wehmeyer; Sven Pischke
Journal:  Viruses       Date:  2016-11-03       Impact factor: 5.048

Review 7.  Hepatitis E: Still Waters Run Deep.

Authors:  Moritz von Wulffen; Dirk Westhölter; Marc Lütgehetmann; Sven Pischke
Journal:  J Clin Transl Hepatol       Date:  2017-09-21

8.  Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study.

Authors:  Sven Pischke; Jean-Marie Peron; Moritz von Wulffen; Johann von Felden; Christoph Höner Zu Siederdissen; Sophie Fournier; Marc Lütgehetmann; Christoph Iking-Konert; Dominik Bettinger; Gabriella Par; Robert Thimme; Alain Cantagrel; Ansgar W Lohse; Heiner Wedemeyer; Robert de Man; Vincent Mallet
Journal:  Viruses       Date:  2019-02-22       Impact factor: 5.048

Review 9.  Hepatitis E Virus in Croatia in the "One-Health" Context.

Authors:  Anna Mrzljak; Lorena Jemersic; Vladimir Savic; Ivan Balen; Maja Ilic; Zeljka Jurekovic; Jadranka Pavicic-Saric; Danko Mikulic; Tatjana Vilibic-Cavlek
Journal:  Pathogens       Date:  2021-06-04

10.  Course of hepatitis E infection in a patient with rheumatoid arthritis and autoimmune hepatitis: A case report.

Authors:  Victoria Thodou; Matthias Buechter; Paul Manka; Guido Gerken; Alisan Kahraman
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.